EKF Diagnostics Holdings Past Earnings Performance
Past criteria checks 1/6
EKF Diagnostics Holdings's earnings have been declining at an average annual rate of -31.3%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 2.8% per year. EKF Diagnostics Holdings's return on equity is 7.3%, and it has net margins of 9.4%.
Key information
-31.3%
Earnings growth rate
-31.3%
EPS growth rate
Medical Equipment Industry Growth | -9.5% |
Revenue growth rate | 2.8% |
Return on equity | 7.3% |
Net Margin | 9.4% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
An Intrinsic Calculation For EKF Diagnostics Holdings plc (LON:EKF) Suggests It's 34% Undervalued
Jul 11EKF Diagnostics Holdings' (LON:EKF) Solid Earnings Have Been Accounted For Conservatively
Mar 27EKF Diagnostics Holdings plc (LON:EKF) Just Reported Earnings, And Analysts Cut Their Target Price
Mar 23These 4 Measures Indicate That EKF Diagnostics Holdings (LON:EKF) Is Using Debt Reasonably Well
Mar 21EKF Diagnostics Holdings plc's (LON:EKF) Low P/S No Reason For Excitement
Jan 31EKF Diagnostics Holdings plc (LON:EKF) Shares Could Be 44% Below Their Intrinsic Value Estimate
Dec 22EKF Diagnostics Holdings plc (LON:EKF) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jul 01Calculating The Fair Value Of EKF Diagnostics Holdings plc (LON:EKF)
Mar 30At UK£0.44, Is It Time To Put EKF Diagnostics Holdings plc (LON:EKF) On Your Watch List?
Jan 31What Does EKF Diagnostics Holdings plc's (LON:EKF) Share Price Indicate?
Oct 06Here's Why We Think EKF Diagnostics Holdings (LON:EKF) Might Deserve Your Attention Today
Aug 16Some EKF Diagnostics Holdings plc (LON:EKF) Analysts Just Made A Major Cut To Next Year's Estimates
Apr 14Downgrade: Here's How Analysts See EKF Diagnostics Holdings plc (LON:EKF) Performing In The Near Term
Mar 31An Intrinsic Calculation For EKF Diagnostics Holdings plc (LON:EKF) Suggests It's 33% Undervalued
Nov 29Investors Will Want EKF Diagnostics Holdings' (LON:EKF) Growth In ROCE To Persist
May 11A Look At The Fair Value Of EKF Diagnostics Holdings plc (LON:EKF)
Apr 20EKF Diagnostics Holdings plc Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next
Apr 02Rainbows and Unicorns: EKF Diagnostics Holdings plc (LON:EKF) Analysts Just Became A Lot More Optimistic
Mar 31EKF Diagnostics Holdings plc's (LON:EKF) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Mar 09EKF Diagnostics Holdings (LON:EKF) Has Rewarded Shareholders With An Exceptional 804% Total Return On Their Investment
Feb 17At UK£0.72, Is EKF Diagnostics Holdings plc (LON:EKF) Worth Looking At Closely?
Jan 26What Do The Returns On Capital At EKF Diagnostics Holdings (LON:EKF) Tell Us?
Jan 06Is EKF Diagnostics Holdings plc (LON:EKF) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 19EKF Diagnostics Holdings plc (LON:EKF) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Dec 01Revenue & Expenses Breakdown
How EKF Diagnostics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 51 | 5 | 12 | 2 |
31 Mar 24 | 52 | 4 | 13 | 2 |
31 Dec 23 | 53 | 2 | 14 | 2 |
30 Sep 23 | 54 | -5 | 14 | 2 |
30 Jun 23 | 56 | -13 | 14 | 2 |
31 Mar 23 | 61 | -11 | 15 | 2 |
31 Dec 22 | 67 | -10 | 16 | 2 |
30 Sep 22 | 74 | -1 | 17 | 1 |
30 Jun 22 | 81 | 9 | 17 | 1 |
31 Mar 22 | 81 | 12 | 14 | 1 |
31 Dec 21 | 82 | 16 | 11 | 1 |
30 Sep 21 | 80 | 16 | 13 | 1 |
30 Jun 21 | 77 | 16 | 15 | 1 |
31 Mar 21 | 71 | 14 | 16 | 1 |
31 Dec 20 | 65 | 11 | 17 | 1 |
30 Sep 20 | 58 | 9 | 14 | 2 |
30 Jun 20 | 50 | 6 | 12 | 2 |
31 Mar 20 | 47 | 5 | 12 | 2 |
31 Dec 19 | 45 | 4 | 13 | 2 |
30 Sep 19 | 44 | 7 | 12 | 2 |
30 Jun 19 | 44 | 11 | 12 | 2 |
31 Mar 19 | 43 | 10 | 12 | 2 |
31 Dec 18 | 43 | 10 | 12 | 2 |
30 Sep 18 | 41 | 7 | 13 | 2 |
30 Jun 18 | 40 | 4 | 13 | 2 |
31 Mar 18 | 41 | 3 | 14 | 2 |
31 Dec 17 | 42 | 3 | 14 | 2 |
30 Sep 17 | 42 | 2 | 13 | 2 |
30 Jun 17 | 43 | 1 | 13 | 3 |
31 Mar 17 | 41 | 1 | 12 | 3 |
31 Dec 16 | 39 | 0 | 11 | 3 |
30 Sep 16 | 36 | -11 | 16 | 4 |
30 Jun 16 | 33 | -22 | 21 | 5 |
31 Mar 16 | 31 | -18 | 16 | 5 |
31 Dec 15 | 30 | -14 | 11 | 5 |
30 Jun 15 | 35 | 4 | 4 | 0 |
31 Mar 15 | 36 | 0 | 9 | 0 |
31 Dec 14 | 37 | -5 | 14 | 0 |
30 Sep 14 | 37 | -4 | 16 | 0 |
30 Jun 14 | 34 | -3 | 16 | 0 |
31 Mar 14 | 33 | -2 | 15 | 0 |
31 Dec 13 | 32 | -1 | 13 | 0 |
Quality Earnings: EKF has a large one-off loss of £1.6M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: EKF became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EKF's earnings have declined by 31.3% per year over the past 5 years.
Accelerating Growth: EKF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: EKF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).
Return on Equity
High ROE: EKF's Return on Equity (7.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 11:47 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EKF Diagnostics Holdings plc is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Julie Simmonds | Canaccord Genuity |
Jens Lindqvist | Investec Bank plc (UK) |
Julie Simmonds | Panmure Liberum |